Skip to main content
2seventy bio, Inc. (TSVT)
NASDAQ: TSVT · IEX Real-Time Price · USD
4.255
-0.035 (-0.82%)
At close: Apr 26, 2024, 4:00 PM
4.320
+0.065 (1.53%)
After-hours: Apr 26, 2024, 6:26 PM EDT

2seventy bio Revenue

In the year 2023, 2seventy bio had annual revenue of $100.39M with 9.72% growth. Revenue in the quarter ending December 31, 2023 was $10.68M, a -80.98% decrease year-over-year.

Revenue (ttm)
$100.39M
Revenue Growth
+9.72%
P/S Ratio
2.17
Revenue / Employee
$366,376
Employees
274
Market Cap
218.33M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023100.39M8.89M9.72%
Dec 31, 202291.50M36.97M67.81%
Dec 31, 202154.52M-193.60M-78.03%
Dec 31, 2020248.12M203.83M460.15%
Dec 31, 201944.30M-10.28M-18.84%
Dec 31, 201854.58M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Auna S.A. 1.04B
Accuray 447.48M
23andMe Holding Co. 247.99M
Adaptimmune Therapeutics 60.28M
AVITA Medical 51.57M
Foghorn Therapeutics 34.16M
uniQure 15.84M
Ovid Therapeutics 391.70K
Revenue Rankings

TSVT News

More News